Tukysa Availabtlity in India

• AVAILABILITY IN MAHARASHTRA

Tukysa has an active pharmaceutical ingredient, tucatinib, which is potently used to treat adult patients with HER2-positive breast cancer in combination with some other drugs. It is not known if Tukysa is safe and effective for children. Before taking Tukysa, it is important to tell the healthcare provider about any liver problem or pregnancy, as it can cause hypersensitivity and harm to the fetus. It is available in Maharashtra, and the cost of Tuksya in Mumbai is pocket efficient.

While taking the drug, it is advised to patients to swallow Tukysa tablets whole and not to chew, crush, or split them before swallowing. If the tablet is broken, cracked, or not otherwise intact, it is advised not to use it and discard it immediately. Patients are advised to take Tukysa approximately 12 hours apart and at the same time each day, with or without a meal. If the patient vomits or misses a dose of Tukysa, it is instructed to take the next dose at its usual scheduled time. When Tukysa is given in combination, the recommended dosage of capecitabine is 1000 mg/m2 orally twice daily, taken within 30 minutes after a meal. Capecitabine and Tukysa can be taken at the same time. 

You can readily purchase this drug at cheaper rates as the cost of Tucatinib in Noida is 

much more reasonable and pocket efficient.

• USE IN SPECIFIC POPULATION

1. Pregnancy- 

As shown in some animal studies and the method of action of tucatinib, it is found that it can potentially cause fetal harm if taken by pregnant women. So it is advised not to take it by a pregnant woman, and always tell the healthcare provider if you are pregnant before starting the treatment.

Lactation-

There is no such data on the presence of tucatinib in milk. Metabolites of TUKSYA in human milk or their effects on the breastfed child or milk production still need to be discovered as there are no studies present to show it. But because of the potential for serious adverse reactions in breastfed children, it is advised not to breastfeed.

For further information about the use of the drug in a specific population and Tukysa cost in India, you can visit us at https://www.indianpharmanetwork.in/

• COMPOSITION

The active ingredient of Tukysa is tucatinib, and the list of inactive ingredients contains copovidone, crospovidone, sodium chloride, potassium chloride, sodium bicarbonate, colloidal silicon dioxide, magnesium stearate, and microcrystalline cellulose in tablet core. In Tukysa tablet coating, a yellow film coat is made up of polyvinyl alcohol, titanium dioxide, macrogol/polyethylene glycol, talc, and yellow iron oxide non-irradiated. It is to note that the use of Tukysa in combination with capecitabine and trastuzumab is not recommended in patients with severe renal impairment because, in the case of patients with severe renal impairment, capecitabine is contraindicated. 

• DESCRIPTION

Tucatinib is a kinase inhibitor. The molecular weight of Tucatinib is 480.52 g/mol. Tucatinib is supplied as 50 mg and 150 mg film-coated tablets for oral use. Each Tukysa 50 mg tablet contains potassium and sodium. To know more about Tukysa tablets cost, you can visit us at Indian Pharma Network; we will be happy to help you. 

• INDIAN PHARMA NETWORK

This medicine is under additional monitoring, which states that it is monitored even more intensively than other medicines. As it is therapeutically used in Breast Neoplasms and Neoplasm Metastasis, it requires extensive care. This drug has been shown to improve the length of time patients with advanced or metastatic HER2-positive breast cancer lived without their disease worsening.

You can get this drug under a prescription and from an authorized dealer. Indian Pharma Network is among the certified dealers and Tukysa suppliers in India, which has been supplying genuine life-saving drugs for more than 8 years globally. 

• EFFECT ON FERTILITY

It is advised in females of reproductive potential to use effective contraception during treatment with tucatinib and for at least 1 week after the last dose. 

Male patients are advised with female partners of reproductive potential to use effective contraception during treatment with tucatinib and for at least 1 week after the last dose. 

Based on findings from animal studies, it is found that Tukysa may impair male and female fertility.

• WARNINGS AND PRECAUTIONS

 Diarrhea: Severe diarrhea, including dehydration and acute kidney injury, which could be fatal and cause death, has been reported. It is advised to administer antidiarrheal treatment as clinically indicated. The dose can be interrupted, reduced, or permanently discontinued for TUKYSA based on severity.

Hepatotoxicity: Severe hepatotoxicity has been reported on TUKYSA. Monitoring of ALT, AST and bilirubin before starting TUCATINIB is done every 3 weeks during treatment and as clinically indicated. Interrupt dose, dose reduction, or permanently discontinue TUKYSA based on severity.

 Embryo-Fetal Toxicity: TUKYSA can actively cause fetal harm. It is advised to patients of the potential risk to a fetus and to use effective contraception.

To buy Tukysa online in India, you can call us at +91 9310090915 or visit us at  Indian Pharma Network.